Evidence map›Paper›PMID 37737226›Full record

ArticleeLife2023

PerTurboID, a targeted in situ method reveals the impact of kinase deletion on its local protein environment in the cytoadhesion complex of malaria-causing parasites.

Heledd Davies, Hugo Belda, Malgorzata Broncel, Jill Dalimot, Moritz Treeck

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Heledd DaviesSignalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID 0000-0003-3475-0080
Hugo BeldaSignalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, United Kingdom.
Malgorzata BroncelSignalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID 0000-0003-2991-3500
Jill DalimotSignalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-1306-093X
Moritz TreeckSignalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-9727-6657
The Francis Crick Institute · GB

Funding

Cancer Research UK CC0199Cancer Research UK CC2132Medical Research Council CC0199Medical Research Council CC2132Wellcome Trust CC0199Wellcome Trust CC2132
6 · The paper itself

Abstract

Reverse genetics is key to understanding protein function, but the mechanistic connection between a gene of interest and the observed phenotype is not always clear. Here we describe the use of proximity labeling using TurboID and site-specific quantification of biotinylated peptides to measure changes to the local protein environment of selected targets upon perturbation. We apply this technique, which we call PerTurboID, to understand how the

Indexed as

MalariaMalaria, FalciparumParasitesAnimalsErythrocytesHumansPeptidesPhosphotransferasesPlasmodium falciparumProtozoan ProteinsPeptidesPhosphotransferasesProtozoan Proteinscell biologyhost–pathogen interactioninfectious diseasemalariamass-spectrometrymicrobiologyparasitic diseasesP. falciparumphosphoregulationprotein kinases

Identifiers

PMID37737226
PMCPMC10564455
OpenAlexW4386944183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.